Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 1
1982 6
1983 4
1985 4
1986 3
1987 5
1988 6
1989 6
1990 5
1991 9
1992 9
1993 13
1994 11
1995 8
1996 17
1997 33
1998 29
1999 31
2000 35
2001 50
2002 57
2003 79
2004 87
2005 126
2006 128
2007 139
2008 178
2009 204
2010 278
2011 287
2012 353
2013 442
2014 498
2015 579
2016 575
2017 700
2018 720
2019 817
2020 1027
2021 1116
2022 1369
2023 1423
2024 1506
2025 1474
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,015 results

Results by year

Filters applied: . Clear all
Page 1
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs.
Jiang Y, Dai A, Huang Y, Li H, Cui J, Yang H, Si L, Jiao T, Ren Z, Zhang Z, Mou S, Zhu H, Guo W, Huang Q, Li Y, Xue M, Jiang J, Wang F, Li L, Zhong Q, Wang K, Liu B, Wang J, Fan G, Guo J, Chen L, Workman CJ, Shen Z, Kong Y, Vignali DAA, Xu C, Wang H. Jiang Y, et al. Among authors: cui j. Cell. 2025 May 1;188(9):2354-2371.e18. doi: 10.1016/j.cell.2025.02.014. Epub 2025 Mar 17. Cell. 2025. PMID: 40101708 Free article.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, Shao G, Zhang B, Shan Y, Meng Z, Wu J, Gu S, Yang W, Liu C, Shi X, Gao Z, Yin T, Cui J, Huang M, Xing B, Mao Y, Teng G, Qin Y, Wang J, Xia F, Yin G, Yang Y, Chen M, Wang Y, Zhou H, Fan J; ORIENT-32 study group. Ren Z, et al. Among authors: cui j. Lancet Oncol. 2021 Jul;22(7):977-990. doi: 10.1016/S1470-2045(21)00252-7. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143971 Clinical Trial.
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Zhou Q, Xu CR, Cheng Y, Liu YP, Chen GY, Cui JW, Yang N, Song Y, Li XL, Lu S, Zhou JY, Ma ZY, Yu SY, Huang C, Shu YQ, Wang Z, Yang JJ, Tu HY, Zhong WZ, Wu YL. Zhou Q, et al. Among authors: cui jw. Cancer Cell. 2021 Sep 13;39(9):1279-1291.e3. doi: 10.1016/j.ccell.2021.07.005. Epub 2021 Aug 12. Cancer Cell. 2021. PMID: 34388377 Free article. Clinical Trial.
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.
Zhang JL, Li YH, Wang LL, Liu HQ, Lu SY, Liu Y, Li K, Liu B, Li SY, Shao FM, Wang K, Sheng N, Li R, Cui JJ, Sun PC, Ma CX, Zhu B, Wang Z, Wan YH, Yu SS, Che Y, Wang CY, Wang C, Zhang Q, Zhao LM, Peng XZ, Cheng Z, Chang JB, Jiang JD. Zhang JL, et al. Among authors: cui jj. Signal Transduct Target Ther. 2021 Dec 6;6(1):414. doi: 10.1038/s41392-021-00835-6. Signal Transduct Target Ther. 2021. PMID: 34873151 Free PMC article.
Targeting RUNX1 in Macrophages Facilitates Cardiac Recovery.
Amrute JM, Zhu A, Pai YL, Hector-Greene M, An Y, Kim KR, Sheth MU, Padmanabhan A, Lee CY, Yamawaki T, Sicklinger F, Hartman N, Bredemeyer A, Lee CJM, Xu V, Bell L, Harmon T, Shin H, Parvathaneni A, Liu L, Dutta AK, Pruitt D, Barreda J, Chen J, Shroff UN, Nadadur R, Nigro J, Weinheimer C, Kovacs A, Cui J, Wang C, Li CM, Kreisel D, Liu Y, Foo RS, Schneider RK, Engreitz JM, Mann DL, Rulifson I, Jackson S, Ason B, Kramann R, Drakos SG, Leuschner F, Alexanian M, Lavine KJ. Amrute JM, et al. Among authors: cui j. bioRxiv [Preprint]. 2025 Jul 26:2025.07.25.665779. doi: 10.1101/2025.07.25.665779. bioRxiv. 2025. PMID: 40777284 Free PMC article. Preprint.
13,015 results
You have reached the last available page of results. Please see the User Guide for more information.